{"id":130271,"date":"2021-11-09T03:22:16","date_gmt":"2021-11-09T11:22:16","guid":{"rendered":"https:\/\/lifeboat.com\/blog\/2021\/11\/regenerons-covid-antibody-drug-shows-protection-for-up-to-8-months"},"modified":"2021-11-09T03:22:16","modified_gmt":"2021-11-09T11:22:16","slug":"regenerons-covid-antibody-drug-shows-protection-for-up-to-8-months","status":"publish","type":"post","link":"https:\/\/lifeboat.com\/blog\/2021\/11\/regenerons-covid-antibody-drug-shows-protection-for-up-to-8-months","title":{"rendered":"Regeneron\u2019s COVID antibody drug shows protection for up to 8 months"},"content":{"rendered":"<p><a class=\"aligncenter blog-photo\" href=\"https:\/\/lifeboat.com\/blog.images\/regenerons-covid-antibody-drug-shows-protection-for-up-to-8-months2.jpg\"><\/a><\/p>\n<p>The antibody therapy, REGEN-COV, is currently authorized in the United States to treat people with mild-to-moderate COVID-19 and for prevention of infection in those exposed to infected individuals, and others at high risk of exposure in settings such as nursing homes or prisons. [USN: L4N2P640O]<\/p>\n<p>The extended authorization could help boost sales of Regeneron\u2019s antibody cocktail, in the face of competition from oral COVID-19 pills such as those being developed by Pfizer Inc (PFE.N) and Merck &amp; Co (MRK.N).<\/p>\n<hr>\n<p>Regeneron Pharmaceuticals Inc said on Monday a single dose of its antibody cocktail reduced the risk of contracting COVID-19 by 81.6% in a late-stage trial, in the two to eight months period following the drug\u2019s administration.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>The antibody therapy, REGEN-COV, is currently authorized in the United States to treat people with mild-to-moderate COVID-19 and for prevention of infection in those exposed to infected individuals, and others at high risk of exposure in settings such as nursing homes or prisons. [USN: L4N2P640O] The extended authorization could help boost sales of Regeneron\u2019s antibody [\u2026]<\/p>\n","protected":false},"author":534,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[11,1493],"tags":[],"class_list":["post-130271","post","type-post","status-publish","format-standard","hentry","category-biotech-medical","category-law-enforcement"],"_links":{"self":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/130271","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/users\/534"}],"replies":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/comments?post=130271"}],"version-history":[{"count":0,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/130271\/revisions"}],"wp:attachment":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/media?parent=130271"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/categories?post=130271"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/tags?post=130271"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}